Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 4, 2009

Drug Name	Review Type	Class	Manufacturer
Sancuso	New Drug Initial Review	Antiemetic	ProStrakan
Moxatag	New Drug Initial Review	Antibiotic	MiddleBrook
Astepro	New Drug Initial Review	Nasal Preprarations	Meda
Trilipix	New Drug Initial Review	Lipotropics � Other	Abbott
Stavzor	New Drug Initial Review	Anticonvulsant	Noven
Janumet	New Drug Initial Review	Diabetes	Merck
Banzel	New Drug Initial Review	Anticonvulsant	Eisai
Tekturna HCT	New Drug Initial Review	Direct Renin Inhibitor	Novartis
Letairis	New Drug Appeal	Pulmonary Arterial Hypertension	Gilead
Megace ES	New Drug Appeal	Progestin	Par
Bystolic	New Drug Appeal	Beta-Blocker	Forest
Pristiq	New Drug Appeal	SNRI Antidepressant	Wyeth
Keppra XR	New Drug Appeal	Anticonvulsant	UCB
Exforge	New Drug Appeal	Antihypertensive Combination	Novartis
Tekturna	New Drug Appeal	Direct Renin Inhibitor	Novartis